Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CNS 2b”

77 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 77 results

Testing effectiveness (Phase 2)Study completedNCT02632786
What this trial is testing

The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis

Who this might be right for
AL Amyloidosis
Prothena Biosciences Ltd. 129
Testing effectiveness (Phase 2)Study completedNCT01966419
What this trial is testing

Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE)

Who this might be right for
Acute Episode of Overt Hepatic EncephalopathyHepatic Encephalopathy
Ocera Therapeutics, Inc. 231
Testing effectiveness (Phase 2)Ended earlyNCT03919162
What this trial is testing

A Trial to Evaluate the Efficacy and Safety of PQ912 in Patients With Early AD

Who this might be right for
Alzheimer Disease
Vivoryon Therapeutics N.V. 112
Large-scale testing (Phase 3)UnknownNCT05869565
What this trial is testing

Best Solution Identification to Prevent Hyperchloremia Combinations of Sodium Chloride and Sodium Acetate IV Fluids Along With Standard of Care Treatment in Acute Stroke Patients

Who this might be right for
Stroke, Acute
Aga Khan University 80
Large-scale testing (Phase 3)Study completedNCT02169882
What this trial is testing

High-dose Rifampicin for the Treatment of Tuberculous Meningitis: a Dose-finding Study

Who this might be right for
Tuberculosis, Meningeal
Universitas Padjadjaran 60
Early research (Phase 1)WithdrawnNCT02791919
What this trial is testing

Wee1 Kinase Inhibitor AZD1775 and Combination Chemotherapy in Treating Children, Adolescents and Young Adults With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
CNS 2aCNS 2bCNS 2c+3 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07528690
What this trial is testing

Microbiota trAnSplant ThERaPy In hEpatiC Encephalopathy (MASTERPIECE)

Who this might be right for
Hepatic EncephalopathyCirrhosis
VA Office of Research and Development 162
Testing effectiveness (Phase 2)Study completedNCT04410367
What this trial is testing

Study to Establish Image Interpretation Criteria for 18F Fluciclovine PET in Detecting Recurrent Brain Metastases (PURSUE)

Who this might be right for
Brain Metastases
Blue Earth Diagnostics 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT06315751
What this trial is testing

Efficacy and Safety of Gemlapodect (NOE-105) in Adults and Adolescents With Tourette Syndrome

Who this might be right for
Tourette Syndrome
Noema Pharma AG 164
Testing effectiveness (Phase 2)Study completedNCT03703570
What this trial is testing

KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations

Who this might be right for
Parkinson's Disease
Kyowa Kirin Co., Ltd. 502
Testing effectiveness (Phase 2)Active Not RecruitingNCT06254482
What this trial is testing

An Extension Study to Evaluate the Long-Term Safety and Efficacy of Votoplam in Participants With Huntington's Disease (HD)

Who this might be right for
Huntington Disease
Novartis Pharmaceuticals 144
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Testing effectiveness (Phase 2)UnknownNCT02525432
What this trial is testing

Autologous Stem Cell Study for Adult TBI (Phase 2b)

Who this might be right for
Brain Injuries, TraumaticBrain Injuries, AcuteTBI (Traumatic Brain Injury)
The University of Texas Health Science Center, Houston 37
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07709845
What this trial is testing

CC-101 (f/k/a NR1) Neural Stem Cell Transplantation for Adults With Chronic Ischemic Stroke

Who this might be right for
Chronic Ischemic Stroke
Clarion Cells, Inc. 36
Testing effectiveness (Phase 2)Study completedNCT02163993
What this trial is testing

Galcanezumab (LY2951742) in Participants With Migraine Headache

Who this might be right for
Migraine Headache
Eli Lilly and Company 414
Large-scale testing (Phase 3)Study completedNCT00944034
What this trial is testing

Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered as Booster Dose at 12, 18 or 24 Months of Age in Toddlers (12-24 Months) Primed With a Three-Dose Immunization Series as Infants in Study V72P12

Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis Vaccines 1,588
Testing effectiveness (Phase 2)Looking for participantsNCT05104983
What this trial is testing

Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study

Who this might be right for
Tuberous Sclerosis ComplexEpilepsy
Darcy Krueger 64
Testing effectiveness (Phase 2)Active Not RecruitingNCT06777433
What this trial is testing

Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain Metastases

Who this might be right for
Brain Metastases From Solid Tumors
Radiopharm Theranostics, Ltd 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07794670
What this trial is testing

Randomized Study to Evaluate the Effect of Obicetrapib in Participants With Preclinical Alzheimer's Disease

Who this might be right for
Preclinical Alzheimer's Disease
NewAmsterdam Pharma 400
Testing effectiveness (Phase 2)WithdrawnNCT05764122
What this trial is testing

Evaluate the Efficacy and Safety of BIIB131 for Participants With Ischemic Stroke Between 4.5 and 24 Hours After Last Known Well

Who this might be right for
Ischemic Stroke
Biogen
Next Page